Hardware, Robotics & IoT VC Funds

NXTP Ventures, headquartered in Buenos Aires, is a leading venture capital firm in Latin America, focusing on early-stage tech startups. Their portfolio includes high-growth companies like Auth0, Nuvemshop, and Satellogic. With over 130 investments and numerous successful exits, NXTP is known for supporting innovative ventures in SaaS, logistics, and fintech sectors. They typically invest in Seed and Series A rounds, writing checks between $500k and $2 million. NXTP's strategy involves deep engagement with their portfolio companies, providing not just capital but also operational support, strategic guidance, and access to an extensive network of industry specialists and mentors. This approach has helped many of their investments achieve significant growth and market presence​ . The firm’s key team members, such as co-founder Ariel Arrieta, bring a wealth of experience in both investing and operating within the tech ecosystem. NXTP's investments are spread across Latin America, with a strong presence in Brazil, Argentina, Mexico, Chile, and Colombia.

Nysnø Climate Investments is a state-owned Norwegian venture capital fund focused on advancing climate solutions through smart, profitable investments. Established in 2017 and based in Stavanger, Nysnø targets companies and technologies that directly contribute to reducing greenhouse gas emissions. The fund invests across sectors such as renewable energy, battery technology, offshore wind, and sustainable materials, supporting companies in their growth and commercialization phases. Nysnø has made significant strides in the green industry, with notable investments in companies like Morrow Batteries, a leader in sustainable battery production, and Vårgrønn, which develops offshore wind projects. The fund also emphasizes the importance of building new green value chains and has recently expanded into international investments, including participation in ArcTern Ventures II, a cleantech fund with a focus on North America and Europe. Primarily investing in companies linked to Norway, Nysnø also places a strong focus on long-term profitability, ensuring that its investments yield both financial returns and substantial environmental benefits. Through its portfolio, Nysnø has contributed to the growth of over 185 companies, helping to accelerate the green transition while creating positive societal impacts.

Oak Investment Partners is a leading multi-stage venture capital firm that focuses on high-growth opportunities across several sectors, including information technology, financial services technology, healthcare, and clean energy. Founded in 1978, Oak has invested over $9 billion in more than 525 companies worldwide. The firm is known for its hands-on approach, offering comprehensive support and strategic assistance through its extensive network of industry experts. Oak's portfolio includes notable companies such as Castlight Health, Zayo Group, Kayak, Benefitfocus, and Protean Electric, among others. Their investment strategy spans early to late-stage investments, including growth equity and PIPE (private investment in public equity) investments. Oak Investment Partners has built a reputation for its ability to identify transformative opportunities and support them through long-term, steady guidance​. The firm is headquartered in Norwalk, Connecticut, with additional offices in California. The team includes experienced professionals like Managing Partners Bandel Carano, Ed Glassmeyer, Fred Harman, and Ann Lamont, who bring deep domain expertise and a consistent investment philosophy to the table​.

OATV (O'Reilly AlphaTech Ventures) is an early-stage institutional seed investment firm founded in 2005 by Mark Jacobsen, Tim O'Reilly, and Bryce Roberts and based in Mill Valley, California. The firm is widely credited as one of the pioneers that created the institutional seed category, raising its first dedicated seed fund at a time when most venture firms deployed exclusively at Series A and later. OATV's thesis centers on backing disruptors, innovators, and 'alpha geeks' — the early-adopter technologists that O'Reilly Media has cultivated for decades — and channeling the reach and relationships of the O'Reilly ecosystem into each investment. OATV has raised three institutional funds: Fund I at $51 million in 2005, Fund II at $59 million in 2010, and Fund III at $85 million in 2012, deploying typical checks of approximately $500,000 to $1 million at the seed stage. Across 70 disclosed investments the firm has backed iconic consumer and developer-focused companies including Foursquare, Bit.ly, Codecademy, GoodData, Get Satisfaction, Fastly — which IPO'd on the NYSE — Planet Labs, Acquia, and Signal Sciences, which was acquired by Fastly. In 2015 Managing Director Bryce Roberts launched Indie.vc, an experiment in funding profitable, customer-funded companies that later evolved into the Calm Company Fund. OATV leads rounds and has slowed new deployment significantly in recent years, with its last disclosed new investment in Miso in December 2022. The platform remains active managing its existing portfolio while Roberts focuses on the Indie and Calm Company work. The firm's early conviction that seed deserved its own institutional discipline — and its rich connections to the practitioner community through O'Reilly Media — produced a portfolio that shaped much of the modern developer-tools and SaaS landscape.

Obvious Ventures, founded in 2014 and based in San Francisco, is a venture capital firm focused on early and growth-stage investments. The firm emphasizes investments that align with their "world positive" approach, targeting sectors like planetary health, human health, and economic health. This mission-driven investment strategy seeks to support companies that create a positive impact on the world while generating significant financial returns. Notable investments by Obvious Ventures include Beyond Meat, Medable, and Dexterity. Beyond Meat, known for its plant-based meat products, went public in 2019, marking a significant milestone for the firm. Medable provides a cloud-based platform for decentralized clinical trials, while Dexterity develops AI-driven robotic systems for managing warehouses. Obvious Ventures has a diverse portfolio of over 130 companies, with successful exits including Recursion Pharmaceuticals, Lilium, and Proterra. The firm's portfolio spans various industries such as AI, biotech, fintech, and sustainable consumer goods. The team at Obvious Ventures includes co-founders Ev Williams, James Joaquin, and Vishal Vasishth, who bring extensive experience in entrepreneurship and venture capital. They are committed to supporting visionary founders who are building transformative companies.

OCA Ventures, based in Chicago, is an early-stage venture capital firm that has been investing since 1999. The firm primarily targets technology, financial services, education, and healthcare technology sectors. Their investment strategy focuses on Seed, Series A, and Series B rounds, with typical initial investments ranging from $1 to $4 million. They often lead the rounds in which they participate. Notable companies in their portfolio include SpotHero, a parking app; Base CRM, a cloud-based customer relationship management software; Pangea, an online money transfer service; and Cleversafe, a cloud-based data storage system. Other significant investments include dv01, LogicGate, and Placer.ai. OCA Ventures is also known for its OCA EDGE program, which invests $50,000 to $200,000 in seed rounds of about $1.5 million or less. This program is designed to support early-stage startups with potential for dramatic growth. The firm has a strong track record of successful exits, including the sale of Cleversafe to IBM and the IPO of Marqeta. Led by CEO Jim Dugan and co-founders John Dugan and Peter Ianello, OCA Ventures leverages a robust network of strategic relationships to support their portfolio companies and drive their growth.

Oceanpine Capital, founded in 2016, is a growth equity investment firm with offices in Beijing, Hong Kong, and Silicon Valley. The firm focuses on investing in disruptive technologies within sectors such as semiconductors, AI, 5G, IoT, big data, enterprise software, and biotech. Oceanpine aims to build long-term partnerships with visionary entrepreneurs to develop world-class companies. Oceanpine Capital has raised significant funds, including a $400 million debut fund and another $400 million for Fund II. The firm has invested over $1 billion across more than 40 companies in China and the US. Notable portfolio companies include Enflame Technology, Ansun Biopharma, Horizon Robotics, Black Sesame, and TigerGraph. Oceanpine's investment strategy emphasizes DeepTech and innovative growth companies, aligning with their commitment to fostering advancements in technology and healthcare sectors​.

Oceans Ventures is an early-stage venture capital firm headquartered in New York, focusing on Pre-Seed and Seed Stage investments. They prioritize building strong, technically proficient teams and invest across sectors including B2B, SaaS, Cloud, AI, and Web3 infrastructure. The firm's notable investments include companies like Carbon Counts, Virtualness, and Lean Financial, which span industries from online gaming to financial services. The firm is managed by experienced professionals such as Brian Lew, Sara Barek, Glenn Handler, Joshua Rahn, and Steven Rosenblatt, who bring a hands-on approach to supporting their portfolio companies. Oceans Ventures emphasizes a collaborative model, actively assisting startups in recruiting top talent and refining their operational strategies​. Their investment strategy is characterized by a strong focus on teams with high integrity, deep domain expertise, and a commitment to growth. Oceans Ventures primarily invests in US-based companies located in talent-rich cities like New York, San Francisco, LA, and Boston.

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odyssee Venture is an independent Paris-based private-equity and venture-capital management company founded in 1999, headquartered at 26 rue de Berri in the 8th arrondissement, and one of the earliest AMF-accredited independent asset managers in France. The firm was co-founded by Mathieu Boillet and Sebastien Sassolas, who previously ran the venture-capital activities of the Banques Populaires Group through SPEF — historically France's first institutional venture investor. Over more than 25 years Odyssee has raised over EUR 750 million across FCPI, FIP, and FCPR vehicles and has financed roughly 200 French growth SMEs. Odyssee leads rounds and focuses on growth-stage investments in French SMEs spanning business and consumer products, financial services, healthcare and life sciences, SaaS, manufacturing and industrials, and e-commerce — deploying tickets from EUR 1 million to EUR 10 million with a typical average around EUR 5 million. Across 181 disclosed investments the portfolio includes BrightHeart, a prenatal ultrasound AI company for which Odyssee led an EUR 11 million Series A in January 2026 following five FDA approvals in 2025; Veesion, an AI shoplifting-gesture detection company that raised EUR 38 million to expand into the US; VitaDX, a urine-based cancer diagnostics firm; PeopleSpheres; Ekinops; Scaled Risk; and GymGlish. Odyssee's 25-year track record spans multiple economic cycles and fund formats, giving it an unusually deep bench of relationships across the French growth-company ecosystem. The firm's FCPI and FIP products are distributed to retail investors, making it one of the few French VCs with both institutional and retail LP exposure — a breadth that supports consistent capital formation across market conditions.

OIF Ventures is a Sydney-based venture capital firm that focuses on backing early-stage companies, particularly in the B2B SaaS, fintech, cybersecurity, and marketplace sectors. Established in 2016, OIF Ventures has built a reputation for its founder-centric approach, working closely with ambitious entrepreneurs to help them scale and succeed globally. With over $500 million in assets under management, the firm provides more than just capital—offering strategic guidance, a deep investor network, and support for global expansion, particularly into the U.S. market. Their portfolio includes notable companies like Go1, Instaclustr, and Kasada, reflecting their investment focus on scalable, tech-driven businesses with the potential for significant impact. OIF Ventures typically invests at the Seed, Pre-Series A, and Series A stages, but has flexibility in supporting companies through later rounds as well. The firm is sector-agnostic but prioritizes founders with strong leadership skills and businesses with a clear market advantage and commercial validation. Their mission is to partner with exceptional founders, helping them not only to grow their businesses but also to develop personally as leaders.

Oita Venture Capital Co., Ltd. is a regional Japanese venture capital and private equity firm headquartered in Oita City, Oita Prefecture, founded in 1997 and operating as the venture-capital arm of Oita Bank Ltd. One of Kyushu's longest-running institutional venture investors, the firm focuses almost exclusively on the Oita region and the broader Kyushu ecosystem, with occasional investments elsewhere in Japan. Oita VC specializes in growth capital, management buyouts, and turnaround investments in local small- and mid-sized enterprises, with particular emphasis on promising venture companies possessing differentiated technology or products and targeting IPO. Thematic priorities include agriculture and corporate farming, renewable energy, technology, and growth and turnaround opportunities for SMEs contributing to the regional economy. The firm leads rounds and operates a series of funds, with Oita VC Success Fund No. 6 as the current active vehicle. Across the firm's history, approximately 70 disclosed investments have been made across 61 companies, resulting in 11 IPO exits — notable listings include iQPS in satellite SAR imaging, QD Laser in semiconductor lasers, and Thinca in payments. Recent deployment has been measured at roughly one new investment per year, including INSPIRATION PLUS at Series A in 2024, GexVal in drug discovery in January 2025, and ATOMica at Series B-III in February 2026, the firm's most recent disclosed investment. Oita VC's role extends beyond financial return to regional economic development: by systematically backing and listing locally grown technology companies, the firm helps anchor high-skill employment and entrepreneurial activity in a prefecture that otherwise sits outside Japan's main technology corridors.

Okapi Venture Capital, established in 2005 and based in Newport Beach, California, focuses on seed and early-stage investments in the information technology and life sciences sectors. The firm has made 83 investments and has 18 notable exits, including companies like Welltok, Qualaroo, and CrowdStrike. Their portfolio includes a diverse range of companies such as Occuspace, which provides smart building solutions, Trellis Research in legal tech, and Daasity, which offers eCommerce analytics solutions. Other significant investments include Babylist, an online discovery platform for baby products, and ChromaCode, which uses data science for advanced molecular diagnostics. Okapi's investment strategy emphasizes supporting innovative startups with high growth potential, often leading seed and Series A rounds. The team is led by co-founders Marc Averitt and Sharon Stevenson, alongside partners like Jeff Bocan and John Waller, who bring extensive experience in venture capital and technology management. The firm is particularly active in the US market and collaborates with co-investors such as SaaS Ventures, Mucker Capital, and Stage Venture Partners, to foster the growth and success of its portfolio companies.

Olive Tree Capital is a dynamic venture capital firm headquartered in Boston, Massachusetts, focusing on early-stage investments across various tech-driven sectors. Notable investments include Uber, Postmates, and Lark, illustrating their keen eye for potential high-growth startups. With a strong portfolio in Artificial Intelligence, Machine Learning, Health & Wellness, and Big Data & Analytics, Olive Tree Capital seeks to back transformative companies from pre-seed through Series A stages. Their investment strategy is characterized by flexibility and an evergreen capital structure, allowing them to lead rounds and provide significant follow-on funding without the constraints of traditional fund timelines. This approach facilitates a long-term partnership with startups, aiming for substantial growth and successful exits, as demonstrated by their involvement in high-profile mergers and acquisitions like those of Bueno Finance and 10 Minute Squad. The firm’s geographic focus extends primarily across the United States, with a pronounced presence in the Boston area. Key team members, including Managing Partners Nichola Eliovits and Yamen Al-Hajjar, bring extensive experience in technology and biotechnology, reinforcing the firm's industry expertise and strategic guidance. Olive Tree Capital’s investment process emphasizes rigorous due diligence and a collaborative approach with co-investors like Y Combinator and Soma Capital. Startups seeking to engage with Olive Tree Capital are encouraged to present a compelling vision for innovation and market disruption, aligning with the firm’s commitment to transformative impact and sustainable growth​.

OTV (formerly Olive Tree Ventures) is a global venture capital firm specializing in digital health startups. Founded in 2015, OTV is based in Tel Aviv and New York, with additional offices in China to support its expansion into the Asia-Pacific market. The firm focuses on mid-growth stage companies developing cutting-edge digital health technologies that aim to revolutionize healthcare globally. OTV’s mission is to back innovative entrepreneurs who are building impactful solutions that address significant healthcare challenges. The firm’s $170 million fund is geared toward investing in companies offering groundbreaking technologies in telemedicine, genomics, AI-driven health platforms, and more. Notable portfolio companies include TytoCare, Lemonaid Health, and Scopio Labs, which are leaders in telehealth and healthcare innovation. OTV’s portfolio reflects its commitment to improving healthcare outcomes through technological advancement. With a leadership team boasting decades of experience in healthcare, technology, and private equity, OTV provides more than just capital. The firm actively supports its portfolio companies in scaling their businesses and navigating complex regulatory environments. By bridging innovation from the West with opportunities in North America, Israel, and Asia, OTV is uniquely positioned to help startups thrive in the growing global digital health market.

Omega Venture Partners, based in Palo Alto, California, is a leading venture capital firm specializing in AI, machine learning, data, and automation. Their investment strategy is centered around identifying high-growth companies at the early-growth stage, particularly those that leverage AI to solve significant business challenges. Omega's portfolio includes companies like ZenBusiness, DataRobot, Verbit, and Elemental Machines, showcasing their focus on businesses that deliver transformative solutions across industries. Omega typically invests at the inflection point of a company’s growth, providing funding between $1M and $10M per round. Their thematic approach ensures they target companies with large-scale potential, helping them scale rapidly through access to a proprietary network of Fortune 500 executives and strategic partners. This network enables Omega to deliver high-value introductions, mentorship, and go-to-market strategies, adding significant value beyond capital. The firm's leadership, including Managing Partner Gaurav Tewari, has a deep track record in tech investing. Omega's expertise in guiding AI-driven companies makes them a preferred partner for entrepreneurs seeking to revolutionize industries like healthcare, fintech, and digital transformation.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

Omnivore is a leading venture capital firm based in India, focusing on early-stage investments in agritech and food systems. Founded in 2010 by Mark Kahn and Jinesh Shah, Omnivore aims to transform the agricultural sector by supporting startups that enhance productivity, sustainability, and profitability for smallholder farmers and rural communities. The firm’s investment themes include farmer platforms, fintech, B2B agri marketplaces, farm-to-consumer brands, precision agriculture, and post-harvest technologies​. Omnivore's portfolio features notable companies like DeHaat, BharatAgri, and Ecozen, which address critical challenges in the agriculture sector through innovative solutions. The firm recently closed the first round of its third fund, the Omnivore Agritech and Climate Sustainability Fund, with $150 million, aiming to support 25-30 new startups focused on climate-smart agriculture and agrifood life sciences​. Omnivore is also recognized for its significant impact on smallholder farmers, having created substantial economic value and improved agricultural practices across India. The firm has reached over 11.4 million smallholder farmers, enabled $1.44 billion in economic value, and facilitated loans and insurance coverage worth billions​. The investment team, led by Mark Kahn and Jinesh Shah, includes experienced partners and advisors deeply embedded in the agritech ecosystem. Their strategic investments are aimed at generating both financial returns and positive social impact​.

OMRON Ventures Co., Ltd. is the corporate venture capital arm of OMRON Corporation — Japan's TSE-listed industrial automation and healthcare technology conglomerate — founded in July 2014 and headquartered in Minato-ku, Tokyo. The firm exists to create innovation driven by social needs by investing in and jointly developing with startups worldwide whose original technologies address OMRON's priority social challenges. Thematic focus areas span factory automation and industrial IoT, smart cities, digital and connected-health wearables, mobility, and energy management. OMRON Ventures operates two successive funds: OVC 1st Fund from 2014, which invested in approximately 20 startups across factory automation, healthcare, and smart cities; and OVC 2nd Fund established January 2022, which was certified by Japan's Ministry of Economy, Trade and Industry as the first Japanese corporate venture fund exempted from overseas-investment regulations — enabling expanded global deployment. Cumulative fund size across both funds is approximately JPY 15 billion, or roughly $100 million. Across 22 disclosed investments, portfolio companies include LIGHTz, a Skill Transfer AI company for manufacturing that received a Series A investment in May 2025; Sky Labs, a wearable cardiac monitoring company backed in November 2025; HQ Inc.; and avatarin Inc., both invested in February 2025. Vice President Christina Connelly leads the firm's international engagement. OMRON's corporate heritage runs deep: founder Kazuma Tateishi established Kyoto Enterprise Development in 1972, widely regarded as Japan's oldest private venture capital firm. This institutional history, combined with OMRON's active manufacturing and healthcare operations across Asia, the US, and Europe, gives its venture arm privileged visibility into frontier industrial and healthcare technology as a customer, collaborator, and investor simultaneously.

OneVentures is a leading Australian venture capital firm with a global focus, investing in technology and healthcare companies. The firm provides both equity and credit funding, with a particular emphasis on innovative products addressing significant market needs. OneVentures operates through several funds. Their Growth Fund V, which closed at $142 million, focuses on technology and tech-enabled companies, investing up to $20 million per company. This fund targets global themes such as remote work, digitization, clean energy, and healthcare. Additionally, the firm manages the Growth Credit Fund IV and the VGF Credit Fund, providing debt financing to high-growth tech companies, with investments ranging from $500,000 to $10 million per company. In the healthcare sector, OneVentures manages the $170 million Healthcare Fund III, investing in therapeutics, devices, and diagnostics with a clear commercial pathway. This fund is part of the Commonwealth Government’s Biomedical Translation Fund program, aiming to advance promising biomedical innovations. OneVentures' portfolio includes companies like Vaxxas, which develops needle-free vaccine delivery technology, and BiVACOR, known for its artificial heart technology. The firm is known for its hands-on approach, providing strategic guidance and leveraging its extensive network to support the growth and success of its portfolio companies.

One Way Ventures, founded in 2017 and headquartered in Boston, Massachusetts, is a venture capital firm dedicated to investing in immigrant founders. The firm focuses on seed-stage and early-stage companies across various sectors, including logistics, mobility, fintech, proptech, deep tech, consumer technology, healthcare, AI, machine learning, and robotics. Notable investments by One Way Ventures include Brex, Chipper Cash, Classtag, and Momentus. The firm has made significant exits, such as Legalpad, acquired in 2022, and Lynk, a satellite communications company​. The portfolio is diverse, featuring companies like Beacon, an AI-powered workflow automation platform for logistics; Brelyon, a deep tech company creating virtual screens; and Care Academy, a caregiver training platform. Co-founded by Semyon Dukach and Eveline Buchatskiy, One Way Ventures aims to support high-impact global companies driven by the unique perspectives and experiences of immigrant founders. The firm values equal opportunity and the collective potential of humankind, striving to eliminate borders as barriers to innovation and growth​.

OneRagtime is a venture capital platform that focuses on sourcing, financing, and scaling early-stage tech startups across Europe. Founded by Stéphanie Hospital and Jean-Marie Messier, the firm offers a unique investment model that combines flexibility with a fully digitized process, allowing investors to choose how they invest, either through deal-by-deal or via their funds like OneRagtime Rhapsody II and OneRagtime Paragon. The firm invests primarily in seed and Series A stages, with initial investments ranging from €0.5 million to €3 million, and can follow up with investments up to €10 million. OneRagtime targets startups in several sectors, including consumer platforms (gaming, marketplaces, social media, and the creator economy), artificial intelligence, cloud services, cybersecurity, and tech for social good (education, climate, and health). Notable portfolio companies include Groover, an artist promotion platform; PhantomBuster, a no-code data automation tool; and Benefiz, an HR tech platform for managing employee benefits. OneRagtime also emphasizes providing strategic, operational, and business development support to its portfolio companies to ensure their growth and success. With a community-driven approach, OneRagtime offers investors the opportunity to engage deeply with startups, providing not just capital but also expertise and networks to drive innovation and growth in the tech sector.

ONSET Ventures was a storied early-stage venture capital firm founded in 1984 and headquartered in Menlo Park, California. The firm was co-founded by Terry Opdendyk, who served as Founder and General Partner across 30-plus years; David Kelley, the founder of IDEO; and Michael Levinthal. For nearly four decades ONSET specialized in seed and Series A investments in information technology and medical sectors — spanning infrastructure software, media, medical devices, drug delivery, mobile, diagnostics, and broader healthcare. The long-tenured partner bench included Rob Kuhling, who joined as Partner in 1987 following his time at Sun Microsystems, and Shomit Ghose. Over its lifetime ONSET raised nine funds and managed more than $1 billion in cumulative assets under management, backing more than 130 companies and producing four IPOs and 42 acquisitions. Notable exits include Adaptive Insights, the financial planning and analytics platform acquired by Workday for $1.55 billion; NeuroStar, an FDA-cleared transcranial magnetic stimulation device for major depressive disorder; CallidusCloud, a sales performance management platform acquired by SAP; and Apama Medical, a chronic-pain therapy company focused on basivertebral nerve treatment. The firm leads rounds and was particularly active at Series A with an average round size of approximately $8.8 million. ONSET Ventures was officially dissolved on November 27, 2023 and is no longer an active investor. Its website and portfolio documentation are maintained for historical reference. The firm's four-decade run across Silicon Valley's technology and medical-device buildout represents one of the most consistent early-stage track records of its era.

OP Financial Group, through its diverse investment services, offers a wide range of mutual funds, focusing on equities, bonds, and alternative assets like real estate and infrastructure. The OP-Private Equity Strategy fund, for instance, is actively managed and invests globally, focusing on a broad range of companies while promoting sustainable and responsible investing practices. It integrates environmental, social, and governance (ESG) factors into its decision-making processes. The group also runs specialized funds like the OP Finland Infrastructure Fund, targeting infrastructure projects within Finland, focusing on sectors such as renewable energy and public utilities. OP provides flexible investment options, allowing customers to invest with minimal starting amounts and offers owner-customers benefits like no trading fees on mutual funds. Whether you're a new or seasoned investor, OP provides tailored advice, including digital tools for fund recommendations and diversified portfolio options.

Open Circle Capital is a Lithuanian-based early-stage venture capital fund focusing on technology startups in ICT, robotics, high-tech, AI, and IoT. With investments ranging from €100k to €1.5M, they seek to support fast-growing, high-potential startups, especially those led by experienced entrepreneurs with a history of growth and successful exits. The fund typically targets pre-seed and seed stages, aiming to inject capital into innovative solutions in areas like SaaS, logistics, Industry 4.0, and med-tech. Open Circle stands out for its strong emphasis on Lithuanian tech ecosystems while backing companies ready to scale globally. Founded by seasoned professionals, including CEO Audrius Milukas and partners Jens Kristian Damsgaard and William Cardwell, the fund has a deep network and a track record of high-profile exits, such as Paysolut and Teamgate. They are willing to either lead or co-invest in rounds, often collaborating with other VCs, business angels, and accelerators to maximize startups' chances of success. Notable portfolio companies include Whatagraph, Billo, and Frontu. Open Circle is known for its proactive approach in helping startups navigate through growth phases, including technology transfer, team building, and preparing for foreign markets, while allowing founding teams to retain majority control. Startups should approach the fund with a clear and compelling pitch, often best through personal connections with partners.

OpenOcean is a leading pan-European venture capital firm focusing on early-stage investments, particularly in Series A rounds, with an emphasis on data economy, B2B platforms, and enterprise software technology. Founded by the team behind MySQL and MariaDB, OpenOcean leverages its deep technical expertise to identify and support innovative startups that can rapidly scale and achieve global adoption. Notable investments include Truecaller, which has grown into a prominent global communications platform with over 200 million daily active users, and MariaDB, a leading open-source database company that recently went public on the New York Stock Exchange. Other significant portfolio companies include Nosto, a marketing automation tool, and Supermetrics, a global leader in marketing data integration tools. OpenOcean’s investment strategy is data-driven and focuses on sectors such as AI, data infrastructure, DevOps, and automation. They typically invest up to €6 million per company, leading or co-leading the investment rounds. The firm has a strong commitment to fostering diversity and transparency within its portfolio companies, ensuring a supportive environment for founders. The team at OpenOcean, with offices in Helsinki and London, is known for its hands-on approach, helping startups navigate the complexities of scaling their businesses and achieving sustainable growth. This approach has led to the creation of several unicorns and high-growth companies that are transforming their respective industries.

Open Opportunity Fund is a venture and growth investment firm backing B2B software companies across Enterprise IT, Fintech, and People Ops. We focus on business-critical software fueled by cloud, AI, and agentic systems, with 70% of our portfolio companies based in emerging tech hubs across the U.S. in regions often overlooked by traditional VC. Fund I was a $100M vehicle and on the strength of that success, we are now raising Fund II. Our strategy combines early and growth-stage investing to back category-defining companies that transform how organizations manage infrastructure, streamline financial operations, and empower their workforces. The firm was founded by Paul Judge and Marcelo Claure, successful entrepreneurs who have each built and scaled companies to successful exits.

The OpenAI Startup Fund is a $175 million venture capital fund focused on investing in early-stage startups that are using artificial intelligence to create transformative change across a range of industries. These industries include healthcare, law, education, energy, and infrastructure. The fund seeks to partner with companies that are pushing the boundaries of AI technology, aiming to have a profound and positive impact on the world. Managed by a team with deep expertise in machine learning, engineering, talent acquisition, and operations, the fund leverages its connections with major investors like Microsoft. Although OpenAI itself is not an investor in the fund, the initiative is deeply tied to OpenAI’s mission of ensuring that artificial intelligence benefits all of humanity. The fund is particularly focused on empowering founders from underrepresented groups, emphasizing the importance of diversity in the tech industry. The OpenAI Startup Fund is not just a source of capital but also provides strategic support to its portfolio companies, helping them navigate the challenges of scaling AI-driven solutions. Startups that align with the fund’s mission of using AI to increase human productivity and address significant global challenges are encouraged to reach out. The fund represents a strategic effort to accelerate the deployment of ethical, impactful AI technologies that can reshape industries and improve lives.

OpenSpace Ventures is a prominent venture capital firm based in Southeast Asia, known for its strategic investments in transformative tech companies across the region. Established in 2014, OpenSpace Ventures has backed notable companies like Gojek, Halodoc, and Love, Bonito, which have made significant impacts in their respective industries. The firm focuses on sectors such as fintech, healthcare, e-commerce, and digital media. Their portfolio includes companies like Lista, a financial management platform for individuals and small business owners in the Philippines; Lucence, a precision oncology company; and Nutrition Technologies, which produces sustainable insect-based proteins for agriculture. OpenSpace Ventures employs a hands-on approach, providing not only capital but also strategic guidance and operational support to help their portfolio companies scale and succeed. They manage several funds, including those focused on Series A/B and mid-stage growth investments, and are recognized for their deep expertise and active involvement in the Southeast Asian startup ecosystem​.

OpenView Venture Partners, based in Boston, is a leading venture capital firm focused on expansion-stage B2B software companies. Founded in 2006 by Scott Maxwell, OpenView specializes in product-led growth (PLG), backing high-potential startups in sectors like SaaS, cloud computing, and productivity software. Notable investments include companies like Calendly, Expensify, and UserTesting, which have scaled into industry leaders with the firm’s support. OpenView typically invests between $5 million and $15 million, focusing on companies with $2 million to $20 million in revenue. Their strategy revolves around more than just capital; they provide operational expertise, assisting with areas like pricing, go-to-market strategy, and talent acquisition. Their value-add model means they work closely with portfolio companies to optimize growth and operational efficiency, helping founders build sustainable and scalable businesses. Geographically, OpenView invests primarily in North America, with a keen eye for businesses that are ready to transition from early traction to full-scale market dominance. The firm is known for its deep expertise in the enterprise software space and is selective about partnering with companies that align with its product-led growth thesis. The leadership team, including key partners like Blake Bartlett and John McCullough, are hands-on with portfolio companies, often playing a pivotal role in key hires and strategic decisions. OpenView is particularly known for its content and community efforts, offering valuable industry insights and resources to help software leaders grow faster.

Operator Partners is a venture capital firm that uniquely operates with its own capital, investing in technology companies from the pre-seed to Series B stages. Founded and led by experienced entrepreneurs, the firm provides support beyond financial investment, focusing on helping companies with business building and scaling challenges that arise between board meetings. Operator Partners has a hands-on approach, offering guidance based on their own entrepreneurial experiences. They engage with founders on various aspects such as product development, customer acquisition, fundraising, recruiting, and establishing organizational culture. The firm does not lead funding rounds or take board seats but assists in finding lead investors if needed. The team includes General Partners Amit Avner, Gil Shklarski, Nat Turner, and Zach Weinberg, along with Partner Olivia Benjamin. This team brings extensive expertise from founding and scaling successful companies themselves, making them well-equipped to support their portfolio companies effectively.

Option3 Ventures (O3V) is a New York-based strategic cybersecurity-specialist private-equity and venture-capital firm founded in 2014 by Managing Partner Manish Thakur. The firm is singularly focused on cybersecurity, with an emphasis on Zero Trust architectures, Operational Technology and Industrial Internet of Things security, and network and firmware security. Rick Andlinger joined as Partner and Chief Investment Officer in March 2020, bringing more than 20 years of family-office private equity and VC leadership from Andlinger and Company. The firm's Technology Board includes former CIOs and board members of the US Department of Defense, CIA, and NSA. Option3 leads rounds and has historically operated three vehicles: C1 (2016), a portfolio of three minority investments; CS (2020), a Special Situations vehicle holding four minority stakes with selective board control; and CE (launched late 2023 through 2025), a single roll-up platform that acquires the CS portfolio companies and adds earlier-stage and mid-market Zero Trust businesses. Total current investments and deals exceed $100 million in AUM. Portfolio investments include Onclave Networks, a Zero Trust solution for industrial IoT that was acquired into the ENIGMA platform in August 2024; Veracity Industrial Networks, an SDN-based industrial security company; Dark Cubed, enterprise-grade cyber for SMBs; and Dellfer, an automotive and IoT firmware security company acquired in January 2025 with an additional investment in March 2025. The ENIGMA roll-up platform now fuses Onclave, Veracity, and Dellfer. Option3's sector specialization is its defining characteristic: by focusing entirely on cybersecurity and building a platform that consolidates complementary technologies, the firm acts as more than a financial investor — it functions as an architect of integrated security infrastructure.

Orbia Ventures is the corporate venture capital arm of Orbia, a multinational company focused on advancing life globally. Orbia Ventures supports startups developing groundbreaking solutions in areas like climate tech, decarbonization, sustainability, circular economy, food security, water infrastructure, data access, and energy storage. With a strong commitment to addressing the world's biggest challenges, Orbia Ventures invests in early- and growth-stage companies that align with its mission to create resilient and future-fit communities. The firm provides more than just capital; it offers extensive business development support, operational expertise, and opportunities for commercial collaborations within Orbia’s broader network. Orbia Ventures helps build strong management teams and leverages its relationships to open new business opportunities for portfolio companies. Notable investments include Tortuga AgTech, which uses advanced robotics to enhance agricultural productivity, Verdagy, a leader in green hydrogen production, and Ascend Elements, which focuses on recycling lithium-ion batteries to create advanced battery materials. Other standout portfolio companies include Type One Energy (fusion energy), Deepomatic (AI-powered visual automation), and Greeneye Technology (precision agriculture). These companies reflect Orbia Ventures' commitment to driving impactful innovation across critical sectors.

OrbiMed is a leading healthcare-focused investment firm based in New York City, established in 1989. It manages over $18 billion in assets across various investment strategies, including public equity, private equity, and private credit/royalty investments. OrbiMed invests globally in companies spanning the healthcare sector, from biopharmaceuticals to medical devices and healthcare services. OrbiMed’s portfolio includes notable companies like Guardant Health, Adaptive Biotechnologies, and Apollomics, showcasing its strong presence in the biotech and medical device sectors. The firm is known for its ability to back innovative startups and has been instrumental in bringing over 60 new healthcare therapies to market​ ​. For startups and established companies looking to connect with OrbiMed, it is beneficial to demonstrate innovative healthcare solutions with strong potential for market impact. The firm typically leads investment rounds and provides significant strategic support to help companies grow into market leaders.

Origin Ventures is an early-stage venture capital firm based in Chicago, Illinois, founded in 1999 by Steve Miller and Bruce Barron. The firm focuses on investing in high-growth software, marketplace, and consumer businesses that are shaping the Digital Native Economy. Origin Ventures has a strong track record, having raised over $300 million across multiple funds and achieving notable exits with companies like Grubhub, Cameo, Fountain, and Tock​. The firm recently closed its fifth fund at $130 million, exceeding their initial target despite the challenges posed by the COVID-19 pandemic. This new fund continues to emphasize investments in the Digital Native Economy, targeting themes such as the workplace of the future, the creator economy, and the circular economy. Recent investments from this fund include companies like Blueboard, Vivrelle, Veho, Lumanu, and Everee. Origin Ventures operates with a thesis-driven approach and maintains a presence in all four continental U.S. time zones, with offices in Chicago, Salt Lake City, San Francisco, and Washington, D.C. This geographic diversity allows them to be close to elite teams and investment opportunities across North America​. The firm prides itself on its hands-on partnership with founders, offering extensive support from their experienced team of former entrepreneurs, operators, and engineers. This commitment has helped them build a portfolio of companies that have consistently delivered strong returns and defined new market categories.

Orion Venture Partners is an early-stage venture capital firm headquartered in Palo Alto, California, operating the Orion Opportunity Fund I, established in 2019. Though the current fund vehicle was formed that year, the underlying investment team has been active since 2001, having invested in 43 companies with approximately $889 million of cumulative capital deployed and an 87 percent average IRR across trade-sale and IPO exits. The firm positions itself as a differentiated, hands-on investor working alongside founders to scale into category-defining platforms, describing its partners as 'early investors, long-term partners.' The fund's investment parameters include a five-year investment period, early-stage checks of $100,000 to $500,000, and growth-stage checks of $1 million to $5 million, with a target ownership of 7 percent or more per position. Geographic focus spans Greater China and the United States, with a particular emphasis on cross-border technology plays. Thematic priorities include artificial intelligence, medical technology, media and content, retail services, mobile content, wireless and telecom infrastructure, and sports technology. From the 2019 vintage, Orion has made 10 disclosed investments, with notable portfolio companies including Avesha (Kubernetes application services), Verana Networks (5G radio access network equipment), and Paw Paw (consumer food products). Orion Venture Partners takes a long-duration approach to company building, leveraging its partners' two-decade track record of cross-border investing to provide founders with both capital and strategic access across the US and Asia-Pacific markets.

Oriza Ventures is a venture capital fund that focuses on early-stage technology investments, primarily in North America. Founded by seasoned entrepreneurs and investors, Oriza Ventures supports startups with disruptive technological pursuits and innovative business ideas. The firm's portfolio spans various industries, including artificial intelligence, big data, Internet of Things, consumer internet, and medical and health products. The team at Oriza Ventures includes founding partners John Yu, Alex Liang, and Yao Xiao, who bring extensive experience in venture capital and entrepreneurship. They leverage their backgrounds to provide strategic guidance and resources to their portfolio companies. Oriza Ventures' portfolio features a diverse range of companies such as Ayla Networks, an IoT platform for smart home appliances; Bolt, an online checkout platform; and InterVenn Biosciences, which uses AI-driven mass spectrometry for medical applications.

Orlando Health Ventures is the corporate venture capital arm of Orlando Health, one of Central Florida's largest nonprofit integrated healthcare systems, established in 2018 and based in Orlando, Florida. The unit sits inside the Orlando Health Strategic Innovations group alongside The Foundry, Orlando Health's internal innovation and rapid-prototyping engine, giving portfolio companies direct access to clinicians, operating executives, and service-line leaders for evaluation, piloting, and commercial validation. The fund targets early-stage companies whose technologies have the potential to transform care delivery, clinical workflows, and patient outcomes. Orlando Health Ventures has made approximately nine disclosed investments concentrated in medical devices and digital health. Portfolio companies include 410 Medical (rapid IV medication delivery, with a Series B-II round in March 2025 as the firm's most recent disclosed investment), Biostable Science and Engineering (Austin-based heart-valve repair device as an alternative to replacement, with roughly $1.25 million deployed), and Vesalio (neurovascular thrombectomy devices whose NeVa VS system launched at Wellstar Health System in Atlanta). The fund participates in seed through Series B rounds alongside peer health-system corporate venture arms such as UPMC Enterprises. What distinguishes Orlando Health Ventures is its combination of clinician-led diligence and operational pilot capability. Portfolio companies can run structured pilots within the Orlando Health system, gaining real-world evidence and commercial traction while the fund's investment committee evaluates growth trajectory and return potential. The result is a capital partner that brings both funding and a credible path to enterprise healthcare customers.

OS Fund, established in 2014 by Bryan Johnson, is a venture capital firm that invests in early-stage science and technology companies. The firm focuses on sectors such as genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. The goal is to support companies that are developing groundbreaking technologies and solutions to solve significant real-world challenges​. Bryan Johnson, who co-founded the fund, initially invested $100 million of his own money after selling his previous company, Braintree, to PayPal for $800 million. The fund seeks out entrepreneurs who are future-oriented and possess the ambition to create a better future for humanity​. OS Fund has a strong portfolio, including companies like Ginkgo Bioworks, Atomwise, and Verge Genomics. These companies are at the forefront of innovation, working on projects such as self-fertilizing crops, storing data in DNA, and designing new proteins.

Osage Venture Partners (OVP) is a Philadelphia-based venture capital firm that specializes in early-stage investments in B2B software companies. The firm primarily focuses on companies driving innovation in the future of work and education sectors. Since its inception, OVP has invested in over 30 companies, with a strong preference for those with recurring revenue models and deep domain expertise. Notable investments in their portfolio include companies like Sidecar, RiskLens, and ExecOnline. OVP typically invests in post-revenue companies with a revenue run rate between $500,000 and $3 million, focusing mainly on Seed and Series A rounds. They have a hands-on approach, often leading or co-leading investments and joining the boards of their portfolio companies. OVP emphasizes the importance of partnerships, leveraging their extensive network of technology executives and industry experts to support the growth and success of the companies they invest in. Their team is comprised of seasoned investors and former operators who provide strategic guidance and operational support to entrepreneurs.

OSF Ventures is the corporate venture capital arm of OSF HealthCare, a 15-hospital nonprofit integrated health system operating across Illinois and Michigan. Founded in 2015 and headquartered in Peoria, Illinois, OSF Ventures sits within OSF Innovation and invests financially, operationally, and strategically in healthcare companies whose technologies can improve patient outcomes, enhance patient experience, and reduce the cost of care. Mayank Taneja, Vice President of Venture Investments, leads a seven-person team across three successive fund vintages that have grown cumulative AUM to $250 million, anchored by Fund III, a $100 million vehicle launched in January 2022 with a thesis tilt toward alternative care modalities and healthcare workforce retention. The firm participates as a syndicate member at Series A through growth stages and has made approximately 37 investments spanning health information technology, medical devices, therapeutics, diagnostics, and technology-enabled care delivery. The portfolio has produced notable exits including Current Health (acquired by Best Buy in 2021), Health Catalyst (NASDAQ IPO in 2019), and SilverCloud Health (acquired by Amwell in 2021). Recent deployments include Hellocare.ai, Cala, ShiraTronics, Cardiosense ($15.1 million Series A for an AI heart disease biomarker platform), 410 Medical ($6.3 million Series B for pediatric sepsis), and Digital Diagnostics ($75 million Series B, autonomous AI diagnostics). OSF Ventures brings more than just capital to portfolio companies. Its status as an active operating health system means founders gain access to clinical validation environments, practitioner networks, and patient populations that can meaningfully accelerate regulatory and commercial timelines, making the fund a strategic partner in addition to a financial backer.

OTB Ventures is a European venture capital firm based in Amsterdam, focused on deep tech startups across Central and Eastern Europe. They specialize in sectors like space tech, artificial intelligence, automation, fintech, and cybersecurity. Founded by Adam Niewinski and Marcin Hejka, OTB Ventures aims to support founders with unique IP and global ambitions by providing early growth funding. Their portfolio includes notable companies like ICEYE, which specializes in radar satellite imagery; Silent Eight, an AI platform for financial crime detection; and Fractory, an automated on-demand metal manufacturing platform. Other significant investments include Turnkey Lender, an embedded lending platform, and Hydrosat, which provides thermal infrared imagery for analytics. OTB Ventures supports their portfolio companies with business and partner introductions, expertise in sales channels, and strategic guidance for international expansion. They are also involved in syndicating additional financing and preparing companies for successful exits.

OTV (formerly Olive Tree Ventures) is a global specialist venture capital firm exclusively dedicated to digital health, founded in 2015 and headquartered in Tel Aviv, Israel with additional offices in New York, Montreal, and Shanghai. Co-founded by General Partners Mayer Gniwisch, Amir Lahat, and Alejandro Weinstein, who together bring backgrounds spanning healthcare, technology, private equity, and financial services, the firm is widely recognized as Israel's only major VC whose primary investment focus is digital health. Partner Manor Zemer complements the founding team. OTV closed a dedicated $170 million digital-health growth fund in December 2020, anchoring its international expansion including the opening of its Asia office in Shanghai. The firm leads rounds across 45 investments and covers the full arc of digital health: telemedicine and virtual care, genomics, AI-powered clinical decision and diagnostics platforms, digital biomarkers, precision medicine, and next-generation medical-device software. Notable portfolio companies include TytoCare (remote examination kit, whose $50 million round OTV led alongside Insight Partners and Qualcomm Ventures) and Scopio Labs ($16 million Series B that OTV led in December 2023, advancing digital microscopy and AI pathology). Realized exits include Lemonaid Health (acquired by 23andMe) and Emedgene (acquired by Illumina). OTV focuses particularly on companies reaching commercial maturity, partnering with founders to navigate regulatory, reimbursement, and enterprise sales challenges across five continents. Its combination of Israeli innovation sourcing, US capital-market relationships, and Asian commercial networks makes it a genuinely global platform for digital health at growth stage.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outbound Ventures, founded in 2015 and based in New York, focuses on early-stage investments in tech-enabled consumer-facing companies. They have made 54 investments and have had 16 successful exits, including companies like Mented Cosmetics, Hydra Studios, and Fleur Marché. The firm is led by co-founders Jimmy Thermiotis, Luis Gonzalez, and Nael Rasamny. Outbound Ventures prioritizes companies with self-aware and adaptable founding teams and leverages their extensive network across Latin America, the U.S., and the U.K. to support the growth of their portfolio companies. Notable investments include Treinta, a fintech company in Colombia; Nabis, a logistics software for the cannabis industry; and Moonshot Brands, a company focused on e-commerce and consumer goods. Their investment strategy typically involves rounds ranging from seed to Series A, with an average round size of $8 million.

Outlier Ventures, founded in 2014, is a leading force in Web3 investment, specializing in blockchain, AI, and decentralized finance (DeFi). Their notable investments include successful projects like Fetch.ai, Ocean Protocol, Brave, and Boson Protocol. Outlier Ventures operates the Base Camp Accelerator, which has helped over 300 startups raise $350 million in seed funding. The firm’s focus is on the "Open Metaverse" and other cutting-edge sectors such as DePIN (decentralized physical infrastructure networks), real-world assets (RWAs), and privacy-enhancing technologies. Geographically, Outlier Ventures has a global reach, investing across multiple regions and fostering a broad network of partners, including giants like Walmart, Hedera, and Polkadot. Their investment strategy is both visionary and grounded in long-term industry shifts, often emphasizing early-stage, high-potential projects with a tokenized model, particularly in blockchain and AI convergence. They prefer to lead rounds, offering full-spectrum support, from token engineering to growth marketing and fundraising advice. Led by Jamie Burke, Outlier’s team is made up of experts across product, token economies, and fundraising, ensuring startups are equipped with tailored resources at every phase. With accelerators like the DePIN Base Camp, Outlier Ventures is at the forefront of the next Web3 wave, leveraging its vast network and deep sector knowledge to empower founders in emerging technologies.

Outset Capital is a specialized early-stage venture capital firm based in San Francisco, driven by a team of AI practitioners and serial entrepreneurs. Their investment focus is on AI, dev tools, robotics, and the future of work, making them a go-to partner for cutting-edge tech startups. They are particularly known for backing companies at the earliest stages, often before anyone else, with small but strategic investments that do not lead rounds. Instead, Outset prefers to add significant value through their hands-on approach, leveraging their deep operational experience to help founders scale from 0 to 1. Notable portfolio companies include Datology AI, Reflex, and SimpleHash, showcasing their focus on AI and software innovation. Outset Capital typically co-invests with leading firms like Andreessen Horowitz, Sequoia, and Lux Capital, reflecting their strong network and collaborative approach. Led by Ali Rohde, Josh Albrecht, and Kanjun Qiu, all of whom are based in San Francisco, the team’s unique blend of technical expertise and entrepreneurial success offers startups robust support beyond just capital. They maintain an active presence in the Bay Area’s startup community, organizing events and fostering a strong network of founders, engineers, and researchers. For startups looking to partner with Outset, the team values integrity, founder alignment, and a shared vision for long-term impact, making them more than just investors—they’re builders backing builders.

Outsiders Fund, founded in 2020 and based in New York, focuses on early-stage investments in disruptive technologies. The fund backs founders challenging traditional industries with innovative solutions. Outsiders Fund has a diverse portfolio across various sectors, including enterprise software, healthcare, cybersecurity, and aerospace. Notable investments include RaySecur, which provides mail and package security solutions using mmWave imaging technology; Casana, which offers remote patient monitoring via a smart toilet seat; and Dyania Health, which matches patients for clinical trials. Another significant investment is in Apex, a company focused on spacecraft manufacturing​. The fund typically invests in seed and early-stage rounds, with an average round size of $11M. Recent investments include Gradial, a generative AI content creation platform, and PaintJet, a robotics company specializing in painting commercial spaces. Led by Managing Partner Theodore Seem and supported by a team of experienced professionals, Outsiders Fund aims to partner with founders to drive growth and innovation in their respective fields. Their approach involves close collaboration with portfolio companies, providing strategic guidance and facilitating key industry connections.